CDE Consistency Evaluation

This resource is a public Information page belonging to China's Center for Drug evaluation (CDE), the agency that reviews drug registration submissions. It focuses on consistency eValuation, the process by which generic drugs are assessed for quality and therapeutic equivalence agAInst their reference products. Rather than being a Generative AI product, it functions as a searchable regulatory reference that Professionals consult when they need to confirm the status of filings and supplementary submissions.

What it does

The page provIDEs list-style access to records tied to consistency evaluation announcements and supplemental queries. Users can browse entries to see which products have filed, which have subMITted additional materials, and how the review pipeline is progressing. It serves as a primary-source check for regulatory status instead of relying on SECondary summaries.

Key capabilities

• Lookup of consistency evaluation filing announcements
• Access to supplementary submission and query records
• List-based browsing of product entries
• Official regulatory context from a government review body
• Useful cross-reference for phArmacovigilance and registration research

Who it is for

Pharmaceutical regulatory affairs specialists, generic drug developers, quality assurance teams, market access analysts, and researchers tracking China's drug APProval landscape are the primary audiences. It is also relevant to consultants and legal teams who need to verify the official status of a product's evaluation rather than relying on third-party Databases.

How to get started

Open the CDE portal in a browser and navigate to the consistency evaluation list section. Records are typically presented as tables or lists; you can scan by product name, applicant, or date depending on how the page is organized. Because the interface is in Chinese and follows government site conventions, users unfamiliar with regulatory terminology may need to consult a glossary or a colleague. Availability and page layout may change as the agency updates its systems.

Pricing and access caveat

The page appears to be freely accessible as a public government resource, with no account required for bASIc viewing. However, access from outside mainland China may be slow or intermittent, and any specific service terms, download restrictions, or data-use rules should be verified directly on the site. Feature availability, record coveRAGe, and interface details may vary over time and are not guaranteed.